GlaxoSmithKline today released Unaudited  Interim Financial Statements for the three months ended 31 March 2017.

 

Revenue N’million

Q1 2017| N3,850

Q1 2016| N4,152

%age change|-7%

Business day

 

(Loss)/Profit after tax  N’million

Q1 2017| N-8

Deal book 300 x 250
Deal book 300 x 250

Q1 2016| N116

%age change| N/A

 

EPS (Kobo)

Q1 2017|-1k

Q1 2016|10k

%age change|N/A%

 

Download (PDF, 221KB)

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.